Subscribe

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

May 7, 2025

Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical […]

Antalpha Announces Launch of Initial Public Offering

May 6, 2025

SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced that it has launched the roadshow for its proposed initial public offering of 3,850,000 ordinary shares with expected pricing between $11.00 and $13.00 per ordinary share. Antalpha expects to grant the underwriters a 30-day option to purchase an […]

Antalpha Announces Launch of Initial Public Offering

May 6, 2025

SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced that it has launched the roadshow for its proposed initial public offering of 3,850,000 ordinary shares with expected pricing between $11.00 and $13.00 per ordinary share. Antalpha expects to grant the underwriters a 30-day option to purchase an […]

Meltwater unveils Mira, latest AI innovations in 2025 Mid-Year Product Release

May 6, 2025

SAN FRANCISCO, May 06, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer intelligence, today unveiled its latest innovations, led by the premiere of Mira, a game-changing AI teammate marking the next evolution in Meltwater’s AI-powered product suite. Combining the power of AI agents with GenAI, Mira delivers instant insights through […]

Search

Popular News

1

2

3

4

General News